DAM
Doheny Asset Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $224K | Hold |
5,780
| – | – | 0.16% | 77 |
|
|
2021
Q4 | $338K | Sell |
5,780
-450
| -7% | -$26.3K | 0.24% | 67 |
|
|
2021
Q3 | $369K | Sell |
6,230
-470
| -7% | -$27.8K | 0.26% | 69 |
|
|
2021
Q2 | $581K | Hold |
6,700
| – | – | 0.37% | 65 |
|
|
2021
Q1 | $552K | Sell |
6,700
-1,150
| -15% | -$94.7K | 0.37% | 64 |
|
|
2020
Q4 | $714K | Buy |
7,850
+180
| +2% | +$16.4K | 0.5% | 54 |
|
|
2020
Q3 | $307K | Hold |
7,670
| – | – | 0.25% | 78 |
|
|
2020
Q2 | $263K | Sell |
7,670
-16,530
| -68% | -$567K | 0.25% | 78 |
|
|
2020
Q1 | $474K | Hold |
24,200
| – | – | 0.38% | 64 |
|
|
2019
Q4 | $474K | Sell |
24,200
-50
| -0.2% | -$979 | 0.38% | 64 |
|
|
2019
Q3 | $377K | Sell |
24,250
-3,300
| -12% | -$51.3K | 0.33% | 71 |
|
|
2019
Q2 | $559K | Buy |
27,550
+100
| +0.4% | +$2.03K | 0.47% | 57 |
|
|
2019
Q1 | $482K | Sell |
27,450
-8,810
| -24% | -$155K | 0.41% | 61 |
|
|
2018
Q4 | $465K | Buy |
36,260
+4,325
| +14% | +$55.5K | 0.34% | 60 |
|
|
2018
Q3 | $520K | Buy |
31,935
+2,300
| +8% | +$37.5K | 0.27% | 71 |
|
|
2018
Q2 | $336K | Buy |
29,635
+145
| +0.5% | +$1.64K | 0.18% | 82 |
|
|
2018
Q1 | $288K | Buy |
29,490
+15,490
| +111% | +$151K | 0.15% | 91 |
|
|
2017
Q4 | $86K | Buy |
+14,000
| New | +$86K | 0.04% | 108 |
|